The short answer
The leading cause of miscarriage is a chromosome error in the embryo, found in 45% of single miscarriages tested 6,8. Risk rises with age: after IVF, 11.4% of scan-confirmed pregnancies were lost under 30 and 37.7% over 40 in one Chinese study 3. After two or more losses, ESHRE recommends a few tests and advises against many others 1.
A miscarriage after IVF comes after a positive beta, sometimes after a heartbeat on the scan, and after months of treatment and money spent. It is a pregnancy loss in every sense. The questions that follow (was it the embryo, my body, the clinic) deserve specific answers.
This page sets out what is known about why IVF pregnancies miscarry and how the risk changes with age. It then lays out ESHRE's 2022 guideline on recurrent pregnancy loss side by side: the investigations and treatments it recommends, and the ones it does not. ESHRE notes that several investigations and treatments offered to couples after pregnancy loss have not been well studied, and many are on the second list 1,2.
How common is this?
11.4%
pregnancy loss after a scan-confirmed IVF/ICSI pregnancy, women under 30 (two Chinese centres, 5,485 clinical pregnancies; mostly miscarriage, includes stillbirth)3
12.0%
same measure, women aged 30–353
17.8%
same measure, women aged 36–403
37.7%
same measure, women over 40 (only 53 pregnancies in this group)3
29%
total risk of pregnancy loss across 148,494 US assisted-reproduction pregnancies (1999–2002), ranging from 22% to 63% by age and type of treatment5
9.8% vs 32.2%
miscarriage risk at ages 25–29 compared with 40–44, across all 421,201 recognised pregnancies in Norway, 2009–2013 (all pregnancies, not only IVF)4
Reading your report
- Pregnancy loss / miscarriage
- ESHRE uses 'pregnancy loss' for any spontaneous loss before 24 weeks, and reserves 'recurrent miscarriage' for losses all confirmed inside the uterus 1.
- Recurrent pregnancy loss (RPL)
- ESHRE's term for two or more pregnancy losses. It includes biochemical losses and losses after IVF, but not ectopic or molar pregnancies 1.
- Aneuploidy
- An embryo or pregnancy with an extra or missing chromosome. It is a recognised cause of pregnancy loss and becomes more frequent with age 1.
- POC karyotype / array-CGH
- Genetic testing of the pregnancy tissue after a loss. ESHRE prefers array-CGH because it avoids mistaking the mother's cells for the pregnancy's 1.
- Antiphospholipid antibodies (lupus anticoagulant, anticardiolipin)
- Blood tests for antiphospholipid syndrome, a clotting-related condition linked to pregnancy loss that has a treatment 1.
- TSH and TPO antibodies
- Thyroid blood tests. ESHRE recommends both after recurrent loss, with a T4 test if TSH is abnormal 1.
Likely causes, most common first
| Cause | How you'd know | Test that tells you |
|---|---|---|
| A chromosome error in the embryo (aneuploidy) | More likely with older eggs. In 15,169 IVF blastocyst biopsies, aneuploidy rose steadily after age 26, and the chance of a cycle having no normal embryo was 2–6% at 26–37, 33% at 42 and 53% at 44 7. | Genetic analysis of the pregnancy tissue. ESHRE says it is not routine but can be done to explain a loss, preferably by array-CGH 1. |
| Antiphospholipid syndrome | Found only by blood tests; it has a recommended treatment in women with three or more losses 1. | Lupus anticoagulant and anticardiolipin antibodies after two losses; β2-glycoprotein I antibodies can be considered 1. |
| Thyroid disease | Found on blood tests. ESHRE notes subclinical hypothyroidism and thyroid antibodies are common in women with recurrent loss 1. | TSH and TPO antibodies, then T4 if TSH is abnormal 1. |
| A difference in the shape of the uterus (for example a septum) | Found on imaging 1. | Transvaginal 3D ultrasound is ESHRE's preferred test; a 2D scan can also look for adenomyosis 1. |
| Sperm DNA damage | ESHRE describes a growing body of evidence linking sperm DNA damage with recurrent loss, but test methods vary 1,2. | Sperm DNA fragmentation testing can be considered 1. |
| No cause found | ESHRE estimates 40–50% of recurrent pregnancy loss stays unexplained 1. | No further test. ESHRE bases prognosis on your age and full pregnancy history 1. |
What did not cause this
"Stress caused the miscarriage"
ESHRE's guideline says stress is associated with recurrent pregnancy loss but there is no evidence that it directly causes pregnancy loss 1.
"You should have rested more"
A Cochrane review found no evidence that bed rest prevents miscarriage; its two trials (84 women) were small, and neither bed rest at home nor in hospital made a significant difference 16.
"A drink before you knew you were pregnant caused it"
ESHRE describes heavy alcohol use as a possible risk factor, but says women who think alcohol caused a previous loss can be reassured that there is no evidence of a causal link 1.
Why do IVF pregnancies miscarry?
Mostly for the same reason natural pregnancies do: the embryo had the wrong number of chromosomes. A systematic review found chromosome abnormalities in 45% of tissue samples from single miscarriages, and in 39% of miscarriages in women who had already had recurrent losses 6. ESHRE's implantation-failure paper calls embryonic chromosomal disorders the major cause of early pregnancy loss 8.
Age is the main driver. ESHRE says the risk of pregnancy loss is lowest between 20 and 35 and rises rapidly after 40 1. The IVF figures above follow the same pattern 3.
A chromosome-tested embryo lowers this risk but does not remove it, because aneuploidy is not the only cause of miscarriage 14.
What testing is worth doing after one miscarriage, and after two?
ESHRE's guideline covers recurrent pregnancy loss, defined as two or more losses. That count includes biochemical losses and losses after IVF 1. The guideline does not set out a routine workup after a single loss.
After one loss, the test that can explain that particular loss is genetic analysis of the pregnancy tissue, if tissue was collected. ESHRE says it is not routine but can be done for explanation, and recommends array-CGH 1. An abnormal result explains that loss. It does not rule out other causes, and ESHRE notes that no clear effect of this testing on the chance of a baby next time has been shown 1.
After two or more losses, ESHRE recommends a short list of tests, shown in the table below. It rates each test on whether it points to a cause, changes treatment, or predicts the outcome, and several tests that are sometimes offered meet none of these 1.
Which treatments actually help after miscarriage?
For unexplained loss, very few. Progesterone is the most studied. In the PROMISE trial, 836 women with unexplained recurrent miscarriage who conceived naturally took vaginal progesterone or placebo from early pregnancy to 12 weeks. Live birth was 65.8% with progesterone and 63.3% with placebo, which was not a significant difference 9. In the PRISM trial, 4,153 women with bleeding in early pregnancy were randomised. Live birth after 34 weeks was 75% with progesterone and 72% with placebo, also not significant overall 10.
The benefit sits in one group. Among women with three or more previous miscarriages who bled in the current pregnancy, live birth was 72% with progesterone and 57% with placebo 11. ESHRE now says vaginal progesterone may improve live birth in that group 1,2. NICE goes further: it recommends vaginal micronised progesterone for women with a scan-confirmed pregnancy in the uterus who have bleeding and at least one previous miscarriage 12.
These trials were not about progesterone support after an IVF transfer, which is a routine part of treatment. How long to continue it is a question for your clinic.
Heparin and aspirin. For unexplained recurrent loss, ESHRE says the evidence shows they do not improve live birth 1. For inherited thrombophilia, the ALIFE2 trial randomised 326 pregnant women with two or more losses. Live birth was 72% with low-molecular-weight heparin and 71% without 13. The exception is antiphospholipid syndrome with three or more losses, where ESHRE suggests low-dose aspirin before conception plus heparin from a positive test 1.
Immune treatments. ESHRE recommends against lymphocyte immunisation therapy because it does not work and may cause serious harm. It also recommends against steroids, finds no evidence for G-CSF and not enough for intralipid. The one exception is IVIG, and only for women with four or more unexplained losses, based on a single trial 1.
Does a miscarriage after IVF make the next transfer riskier?
The evidence points both ways. In a Beijing cohort of first IVF cycles, women whose first pregnancy miscarried had a similar clinical pregnancy rate next time, but a higher miscarriage rate (14.75% vs 7.41% in women who had not become pregnant) 17. In a US cohort of 2,103 patients having two consecutive euploid frozen transfers, a clinical loss in the first transfer was not followed by a significantly higher loss rate in the second (12.5% vs 10.9%) 18.
Across all pregnancies in Norway, the odds of miscarriage rose with each previous miscarriage: 1.54 times after one, 2.21 after two and 3.97 after three consecutive losses, after allowing for age 4. ESHRE recommends estimating the chance of success from your age and complete pregnancy history, not from the number of losses alone 1.
What about how I feel?
Grief after a miscarriage is common and can last. In a London study of 737 women after early pregnancy loss, 29% met screening criteria for post-traumatic stress at one month and 18% at nine months. Moderate to severe anxiety was reported by 24% at one month 15.
ESHRE calls pregnancy loss a significant negative life event, says repeated losses can intensify the grief, and says clinics should take couples' psychological needs into account 1. Asking your clinic for counselling is an ordinary request.
ESHRE 2022 recurrent pregnancy loss guideline: investigations for couples with two or more losses
| Investigation | ESHRE 2022 position | Why |
|---|---|---|
| Antiphospholipid antibodies (lupus anticoagulant, anticardiolipin IgG and IgM) | Recommended after two losses (strong) | Can identify a cause with a treatment 1 |
| β2-glycoprotein I antibodies | Can be considered after two losses | Treatment improved live birth in one study 1 |
| TSH and TPO antibodies (T4 if TSH abnormal) | Recommended (strong) | Thyroid problems are common in recurrent loss and may be treatable 1 |
| Uterine scan (3D transvaginal ultrasound preferred) | Recommended for all (strong) | Finds uterine shape differences; a 2D scan can check for adenomyosis 1 |
| Male partner's lifestyle (age, smoking, alcohol, exercise, weight) | Recommended (strong) | Suggested link with sperm quality 1 |
| Genetic analysis of pregnancy tissue (array-CGH) | Not routine; can be done to explain a loss | Explains that loss; no clear effect on next outcome 1 |
| Parental karyotype | Only after individual risk assessment | Not needed routinely; chance of a baby stays good even if abnormal 1 |
| Sperm DNA fragmentation | Could be considered | Growing evidence of association; methods vary 1,2 |
| Antinuclear antibodies (ANA) | Could be considered, to explain only | Associated with recurrent loss 1 |
| Inherited thrombophilia screen | Not recommended, except in research or with extra clotting risk | No or weak association with recurrent loss 1,13 |
| NK cell testing (blood or uterine lining) | Not recommended | Cannot select women for treatment; technical problems 1 |
| HLA typing, anti-HLA antibodies, cytokine tests | Not recommended | Not shown to cause loss or to guide treatment 1 |
| Ovarian reserve (AMH, FSH) | Not routinely recommended (strong) | Insufficient evidence of a link with recurrent loss 1 |
| Luteal phase (progesterone) testing | Not recommended (strong) | Inconsistent evidence; no effect on treatment 1 |
| PCOS assessment, fasting insulin and glucose | Not recommended to improve prognosis (strong) | No evidence it predicts or changes outcome 1 |
| Prolactin | Only if periods are irregular or absent | Inconsistent evidence of a link 1 |
| Homocysteine, androgens, LH | Not routinely recommended (strong) | Inconsistent evidence 1 |
| Vitamin D level | Not recommended to find a cause | Supplementation can still be considered 1 |
What's worth checking
- Ask whether tissue from this pregnancy was sent for genetic analysis, and whether array-CGH is still possible 1.
- Write down every pregnancy, including biochemical losses, with dates and outcomes; ESHRE bases prognosis on your complete history 1.
- After two losses, check you have had antiphospholipid antibodies, TSH and TPO antibodies, and a uterine scan 1.
- Before paying for any other test, ask what result would change your treatment.
- Include your partner: ESHRE recommends reviewing his age, smoking, alcohol, exercise and weight 1.
- If you bleed in a future pregnancy after a previous miscarriage, ask about progesterone straight away 12.
- Ask your clinic for counselling or support contacts if you want them 1.
What could change next cycle
16 options, by strength of evidence
- Good evidence it helps 1
- Mixed, or some groups only 5
- Not enough studies yet 3
- Evidence says it doesn't help 7
Ratings follow the evidence reviews cited beside each option, not our opinion.
- Vaginal progesterone if you bleed in a future pregnancy, after three or more lossesMixed, or some groups only
Helps this subgroup only; ESHRE says it may improve live birth, and NICE recommends it after even one previous miscarriage 1,1211
- Progesterone for unexplained recurrent loss without bleedingEvidence says it doesn't help
PROMISE found no significant benefit; ESHRE's recommendation covers only women who bleed 1,9
- Low-dose aspirin plus heparin for antiphospholipid syndromeMixed, or some groups only
ESHRE suggests it with three or more losses; for two losses only within research 1
- Heparin or aspirin for unexplained lossEvidence says it doesn't help
ESHRE: evidence shows no improvement in live birth 1
- Heparin for inherited thrombophiliaEvidence says it doesn't help
ALIFE2: live birth 72% with heparin vs 71% without; ESHRE advises against outside research 1,13
- Levothyroxine for an underactive thyroid (overt hypothyroidism)Good evidence it helps
ESHRE strongly recommends treatment 1
- Levothyroxine with normal thyroid function but positive TPO antibodiesEvidence says it doesn't help
ESHRE strongly recommends against, after two trials showed no gain in live birth 1,2
- IVIG (intravenous immunoglobulin)Mixed, or some groups only
ESHRE: may help only with four or more unexplained losses, based on one trial 1
- Steroids (prednisolone)Mixed, or some groups only
Some benefit in selected women, but ESHRE recommends against because of side effects 1
- IntralipidNot enough studies yet
ESHRE: insufficient evidence, with potential adverse effects 1
- G-CSFEvidence says it doesn't help
ESHRE: a large high-quality trial showed no benefit in unexplained loss 1
- Lymphocyte immunisation therapyEvidence says it doesn't help
ESHRE: no significant effect and possible serious adverse effects 1
- PGT-A (chromosome testing of embryos)Mixed, or some groups only
HFEA: green for reducing miscarriage, red for chance of a baby, grey for older women; ESHRE: insufficient evidence in unexplained RPL 1,14
- Hysteroscopic septum removalNot enough studies yet
ESHRE: the only randomised trial, a small one, showed no benefit 1
- Endometrial scratchingNot enough studies yet
ESHRE: no evidence it improves outcomes in unexplained loss 1
- High-dose folic acid (beyond the standard dose)Evidence says it doesn't help
ESHRE: not shown to prevent loss and possibly harmful unless specifically indicated 1
Questions to ask your doctor
- Was tissue from this pregnancy sent for genetic testing, and if not, can it still be?
- Counting biochemical losses, how many pregnancy losses do I have, and does that put me in ESHRE's recurrent pregnancy loss group?
- Which of ESHRE's recommended tests (antiphospholipid antibodies, TSH and TPO, uterine scan) have I had, and which are still needed?
- If you are suggesting a test or treatment that is not on that list, what evidence is it based on, and what would you do differently depending on the result?
- For my age and embryo numbers, would PGT-A change my chance of a baby, or only my chance of another miscarriage?
- If I bleed in the next pregnancy, what is the plan for progesterone?
Questions people ask
Can the father's age or sperm cause miscarriage?
Possibly. ESHRE notes that most studies link older paternal age with more miscarriage, and recommends assessing the male partner's age, smoking, alcohol, exercise and weight in couples with recurrent loss 1. Sperm DNA fragmentation testing can be considered, although it is not settled which of the many test methods is most useful 2.
Is my first beta hCG level linked to miscarriage risk?
Somewhat. In a Chinese study of 5,485 IVF pregnancies confirmed on scan, pregnancy loss was 5.8% when the day-14 hCG was at or above 695 IU/L and 15.1% below it 3. That is a group pattern; many pregnancies with lower values continued.
How long should I wait after a miscarriage before the next IVF cycle?
There is little good evidence. In one Israeli cohort of 257 women aged 18 to 40 who restarted IVF after a first-trimester loss, a longer wait did not improve the chance of pregnancy, and shorter gaps were linked to a higher chance of live birth 19. The study was retrospective, so ask your clinic whether your recovery or any treatment needs more time.
Can I still have a baby after recurrent miscarriage?
Do the losses have to be one after the other to count as recurrent?
No. ESHRE defines recurrent pregnancy loss as two or more pregnancy losses and does not require them to be consecutive, noting there is no pathophysiological argument for the distinction and that fewer than 10% of couples with recurrent loss have non-consecutive ones 1. Some members of its guideline group recorded their disagreement and keep a three-consecutive-loss definition in their own practice 1.
Why did I miscarry when the embryo was PGT-A tested normal?
Chromosome testing lowers the risk of miscarriage without removing it; the HFEA rates PGT-A green for reducing miscarriage and states plainly that it does not remove the risk entirely 14. Among 2,103 patients having consecutive single euploid frozen transfers, 10.9% of second transfers ended in a clinical loss where the first had not implanted, and 12.5% where the first had ended in a clinical loss 18. Aneuploidy is the leading cause of loss, not the only one 1.
Can a D&C after a miscarriage affect my chances next time?
It is a recognised risk whose size is unclear. A systematic review of 10 prospective studies (912 women examined by hysteroscopy within a year of a miscarriage) found intrauterine adhesions in 19.1%, mild in 58.1% of those cases, with the number of D&C procedures the main factor behind higher rates 20. No study has linked those adhesions to later pregnancy outcomes, and results were similar after expectant, medical and surgical management 20.
My partner seems less affected than me. Is that normal?
It matches the one study that measured both. Among 192 couples followed after miscarriage or ectopic pregnancy at three London hospitals, 7% of partners met screening criteria for post-traumatic stress at one month against 34% of the women, and 6% had moderate or severe anxiety against 30% 21. Some partners do report clinically significant distress, so support is not only for the woman 21.
My TSH is slightly high. Will thyroid tablets prevent another miscarriage?
It depends which thyroid picture you have. ESHRE strongly recommends treating overt hypothyroidism arising before conception or in early pregnancy 1. For subclinical hypothyroidism it calls the evidence conflicting: treatment may reduce the risk of miscarriage, but the possible benefit has to be weighed against the risks, and better studies are needed 1. Women with normal thyroid function and thyroid antibodies should not be given levothyroxine 1.
Is miscarriage more common after IVF than after natural conception?
The published numbers cannot be compared cleanly. A US study of 148,494 assisted-reproduction pregnancies reported total loss of 29%, ranging from 22% to 63% by age and procedure 5, while a Norwegian register of 421,201 recognised pregnancies reported 9.8% at ages 25 to 29 and 32.2% at 40 to 44 4. The populations and the point at which a pregnancy was counted differ. Both show age as the strongest driver 1,4.
How long until a pregnancy test turns negative after a miscarriage?
Longer than most people expect. NICE advises women managing a miscarriage expectantly to do a home urine pregnancy test three weeks afterwards, and to return for individualised care if it is still positive 12. If bleeding and pain have not started, or are persisting or increasing after that period, NICE advises a repeat scan and a discussion of the remaining options rather than waiting 12.
Do most miscarriages after IVF happen before 12 weeks?
In this data, yes. Among 5,485 scan-confirmed IVF and ICSI pregnancies at two Chinese centres, 685 ended in loss: 460 were early miscarriages before 12 weeks and 191 were late miscarriages between 12 and 24 weeks 3. Maternal age, stimulation protocol, cycle type and the day-14 hCG level affected loss mainly before 12 weeks 3. ESHRE still bases prognosis on your age and complete pregnancy history rather than on one milestone 1.
Sources
- ESHRE Guideline Group on RPL, Bender Atik R, Christiansen OB, Elson J, et al. ESHRE guideline: recurrent pregnancy loss. Update 2022 (full guideline, final version January 2023). ESHRE
- ESHRE Guideline Group on RPL, Bender Atik R, Christiansen OB, Elson J, et al. ESHRE guideline: recurrent pregnancy loss: an update in 2022. Hum Reprod Open. 2023;2023(1):hoad002. ESHRE / Human Reproduction Open
- Hu L, Du J, Lv H, Zhao J, Chen M, Wang Y, et al. Influencing factors of pregnancy loss and survival probability of clinical pregnancies conceived through assisted reproductive technology. Reprod Biol Endocrinol. 2018;16:74. Reproductive Biology and Endocrinology
- Magnus MC, Wilcox AJ, Morken NH, Weinberg CR, Håberg SE. Role of maternal age and pregnancy history in risk of miscarriage: prospective register based study. BMJ. 2019;364:l869. BMJ
- Farr SL, Schieve LA, Jamieson DJ. Pregnancy loss among pregnancies conceived through assisted reproductive technology, United States, 1999-2002. Am J Epidemiol. 2007;165(12):1380-1388. American Journal of Epidemiology
- van den Berg MM, van Maarle MC, van Wely M, Goddijn M. Genetics of early miscarriage. Biochim Biophys Acta. 2012;1822(12):1951-1959. Biochimica et Biophysica Acta
- Franasiak JM, Forman EJ, Hong KH, Werner MD, Upham KM, Treff NR, Scott RT Jr. The nature of aneuploidy with increasing age of the female partner: a review of 15,169 consecutive trophectoderm biopsies evaluated with comprehensive chromosomal screening. Fertil Steril. 2014;101(3):656-663. Fertility and Sterility
- ESHRE Working Group on Recurrent Implantation Failure, Cimadomo D, de los Santos MJ, Griesinger G, et al. ESHRE good practice recommendations on recurrent implantation failure. Hum Reprod Open. 2023;2023(3):hoad023. ESHRE / Human Reproduction Open
- Coomarasamy A, Williams H, Truchanowicz E, Seed PT, Small R, Quenby S, et al. A randomized trial of progesterone in women with recurrent miscarriages (PROMISE). N Engl J Med. 2015;373(22):2141-2148. New England Journal of Medicine
- Coomarasamy A, Devall AJ, Cheed V, Harb H, Middleton LJ, Gallos ID, et al. A randomized trial of progesterone in women with bleeding in early pregnancy (PRISM). N Engl J Med. 2019;380(19):1815-1824. New England Journal of Medicine
- Coomarasamy A, Devall AJ, Brosens JJ, Quenby S, Stephenson MD, Sierra S, et al. Micronized vaginal progesterone to prevent miscarriage: a critical evaluation of randomized evidence. Am J Obstet Gynecol. 2020;223(2):167-176. American Journal of Obstetrics and Gynecology
- National Institute for Health and Care Excellence. Ectopic pregnancy and miscarriage: diagnosis and initial management (NG126). Chapter: Management of miscarriage. Published 2019, last updated 17 June 2026. NICE
- Quenby S, Booth K, Hiller L, Coomarasamy A, de Jong PG, Hamulyák EN, et al. Heparin for women with recurrent miscarriage and inherited thrombophilia (ALIFE2): an international open-label, randomised controlled trial. Lancet. 2023;402(10395):54-61. The Lancet
- Human Fertilisation and Embryology Authority. Pre-implantation genetic testing for aneuploidy (PGT-A): treatment add-on ratings. HFEA
- Farren J, Jalmbrant M, Falconieri N, Mitchell-Jones N, Bobdiwala S, Al-Memar M, et al. Posttraumatic stress, anxiety and depression following miscarriage and ectopic pregnancy: a multicenter, prospective, cohort study. Am J Obstet Gynecol. 2020;222(4):367.e1-367.e22. American Journal of Obstetrics and Gynecology
- Aleman A, Althabe F, Belizán J, Bergel E. Bed rest during pregnancy for preventing miscarriage. Cochrane Database Syst Rev. 2005;(2):CD003576. Cochrane
- Yang R, Yang S, Li R, Chen X, Wang H, Ma C, Liu P, Qiao J. Biochemical pregnancy and spontaneous abortion in first IVF cycles are negative predictors for subsequent cycles: an over 10,000 cases cohort study. Arch Gynecol Obstet. 2015;292(2):453-458. Archives of Gynecology and Obstetrics
- Barrett F, Kalafat E, Vessa B, Margolis C, Whitehead C, Werner M, Ata B, Seli E. Biochemical or clinical pregnancy loss after first embryo transfer does not affect subsequent transfer outcome. Reprod Biomed Online. 2026;52(4):105435. Reproductive BioMedicine Online
- Sharon-Weiner M, Gluska H, Farladansky-Gershenabel S, Schreiber H, Wiser A, Shulman A, Hershko-Klement A. Conception after early IVF pregnancy loss: should we wait? Reprod Biomed Online. 2021;42(2):413-419. Reproductive BioMedicine Online
- Hooker AB, Lemmers M, Thurkow AL, Heymans MW, Opmeer BC, Brolmann HA, Mol BW, Huirne JA. Systematic review and meta-analysis of intrauterine adhesions after miscarriage: prevalence, risk factors and long-term reproductive outcome. Hum Reprod Update. 2014;20(2):262-278. Human Reproduction Update
- Farren J, Jalmbrant M, Falconieri N, Mitchell-Jones N, Bobdiwala S, Al-Memar M, et al. Differences in post-traumatic stress, anxiety and depression following miscarriage or ectopic pregnancy between women and their partners: multicenter prospective cohort study. Ultrasound Obstet Gynecol. 2021;57(1):141-148. Ultrasound in Obstetrics & Gynecology
- National Institute for Health and Care Excellence. Ectopic pregnancy and miscarriage: diagnosis and initial management (NG126). Chapters: Symptoms and signs of ectopic pregnancy and initial assessment; Support and information. Published 2019, last updated 17 June 2026. NICE
- NHS. Miscarriage. nhs.uk health A-Z. Last reviewed 31 March 2026. NHS (nhs.uk)